tiprankstipranks
Trending News
More News >
Polyrizon Ltd. (PLRZ)
NASDAQ:PLRZ
US Market
Advertisement

Polyrizon Ltd. (PLRZ) Price & Analysis

Compare
130 Followers

PLRZ Stock Chart & Stats


Polyrizon Ltd. News

PLRZ FAQ

What was Polyrizon Ltd.’s price range in the past 12 months?
Polyrizon Ltd. lowest stock price was $0.55 and its highest was $1200.00 in the past 12 months.
    What is Polyrizon Ltd.’s market cap?
    Polyrizon Ltd.’s market cap is $6.82M.
      When is Polyrizon Ltd.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Polyrizon Ltd.’s earnings last quarter?
      Currently, no data Available
      Is Polyrizon Ltd. overvalued?
      According to Wall Street analysts Polyrizon Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Polyrizon Ltd. pay dividends?
        Polyrizon Ltd. does not currently pay dividends.
        What is Polyrizon Ltd.’s EPS estimate?
        Polyrizon Ltd.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Polyrizon Ltd. have?
        Polyrizon Ltd. has 5,880,763 shares outstanding.
          What happened to Polyrizon Ltd.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Polyrizon Ltd.?
          Currently, no hedge funds are holding shares in PLRZ

          Company Description

          Polyrizon Ltd.

          Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.

          Polyrizon Ltd. (PLRZ) Earnings & Revenues

          Currently, no data available
          Please return soon. This page is being updated.
          Similar Stocks
          Company
          Price & Change
          Follow
          Biodexa Pharmaceuticals
          Salarius Pharmaceuticals
          Quoin Pharmaceuticals
          GRI Bio
          Protagenic Therapeutics

          Ownership Overview

          3.68%96.32%
          Insiders
          Mutual Funds
          3.68% Other Institutional Investors
          96.32% Public Companies and
          Individual Investors

          Options Prices

          Currently, No data available
          ---
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis